4.4.0 Hepatitis C Treatments in Current Clinical Development
4.4.0 Hepatitis C Treatments in Current Clinical Development
Alan Franciscus,
Editor-in-Chief
http://www.hcvadvocate.org
Quick Reference Guide
(www.hcvadvocate.org/hepatitis/hepC/Quick_Ref_Guide.pdf)
Note: Click on the links below to go to find out more about the drugs in development.
Phase 2 — DAA/HCV Inhibitors
Phase 2 – DAA/HCV Inhibitors Combinations without Pegylated Interferon and/or Ribavirin
Phase 3 – DAA/HCV Inhibitors Combinations without Pegylated Interferon and/or Ribavirin
Phase 3 - DAA/HCV Inhibitors plus Pegylated Interferon and Ribavirin
Phase 2 – HIV/HCV Coinfection (all studies)
Phase 3 – HIV/HCV Coinfection (all studies)
Prev | Table of Contents |
Next |
4.3.9 Tarmogen (GI-5005) |
Реклама: |
---|
|